Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
48.19
+0.07 (0.15%)
At close: Aug 27, 2025, 4:00 PM
48.18
-0.01 (-0.02%)
After-hours: Aug 27, 2025, 5:04 PM EDT

Akero Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2020
3,8551,9421,3012,563738896
Upgrade
Market Cap Growth
162.21%49.28%-49.24%247.29%-17.63%41.33%
Upgrade
Enterprise Value
2,8051,1917142,199524606
Upgrade
Last Close Price
48.1927.8223.3554.8021.1525.80
Upgrade
PB Ratio
3.752.592.437.854.363.46
Upgrade
P/TBV Ratio
3.762.592.437.854.363.46
Upgrade
Debt / Equity Ratio
0.040.050.050.030.010.01
Upgrade
Quick Ratio
12.2918.6928.7518.427.4920.47
Upgrade
Current Ratio
12.6619.3829.2718.617.7020.70
Upgrade
Return on Equity (ROE)
-31.14%-39.22%-35.22%-45.20%-47.11%-40.89%
Upgrade
Return on Assets (ROA)
-20.36%-25.37%-23.06%-26.07%-26.90%-24.35%
Upgrade
Return on Capital (ROIC)
-21.19%-26.47%-24.03%-28.33%-29.25%-25.73%
Upgrade
Earnings Yield
-7.37%-12.98%-11.67%-4.37%-13.66%-8.84%
Upgrade
FCF Yield
-6.57%-11.90%-11.18%-3.61%-10.80%-7.92%
Upgrade
Buyback Yield / Dilution
-25.25%-27.71%-34.84%-11.94%-10.69%-108.77%
Upgrade
Updated Aug 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q